A PYMNTS Company

Autumn 2010, Volume 9, Number 2

SEP-10(2)
 |  Dec 21, 2015

In this issue: This issue contains a special bonus, but first we take a look at two recent EU court decisions. Kent Bernard, Sean-Paul Brankin, and Kristina Nordlander & Patrick…

The AZ Judgment: A Green Light for Further Action on Pharma and IP
 |  Sep 29, 2010

Sean-Paul Brankin, Sep 30, 2010 On July 1, 2010, the General Court issued its long awaited judgment in AstraZeneca v Commission, almost five years after AstraZeneca launched its appeal against…

A Dozen of our Year-to-Date Favorites
 |  Sep 29, 2010

Sep 30, 2010 Here you’ll find a link to a complimentary issue that includes a dozen of our most popular articles published year-to-date. We’re offering this free issue to introduce…

Legal Privilege or Legal Inconvenience? Some Reflections on the Last Judgment of the ECJ in Relation to the Akzo Case
 |  Sep 29, 2010

Angela Laghezza, Sep 30, 2010 This article analyzes the concept of Legal Professional Privilege (“LPP”) in EU through the lenses of the Akzo case. It underlines what the recent ECJ…

General Court’s AstraZeneca Judgment Set to Embolden Commission
 |  Sep 29, 2010

Patrick Harrison, Kristina Nordlander, Sep 30, 2010 Five years and two weeks is a long time to wait for a judgment on appeal. For many, it is too long. However,…

The AstraZeneca Decision in the General Court: Some Basic Observations and a Few Interesting Questions
 |  Sep 29, 2010

Kent Bernard, Sep 30, 2010 By its decision of July 1, 2010 in AstraZeneca the General Court upheld the decision of the European Commission that AstraZeneca had abused a dominant…

Loading...